This site supplies research compounds only. Products are not for human or animal consumption.
You must be aged 18 or over to continue.
For laboratory research use only — not for human or animal consumption. Strictly 18+.
Quietly open. We’re taking orders and dispatching as normal while we finish the last of the photography and paperwork. Order with confidence — you’re just here before the official launch.
5 min read·MrPep research team·Updated August 2026
A reference index of compounds encountered in peptide research, grouped by class. Each entry lists what the compound is and its regulatory status — nothing more.
How to read this index. This is a classification reference, not a product catalogue and not a recommendation. Inclusion here is not an offer to supply, and several entries are licensed medicines noted as such. No entry describes effects, outcomes or use in humans or animals, because these materials are supplied only as research reference standards for laboratory work.
Regulatory status, defined
Research use only — not authorised as a medicine in the UK; supplied as a laboratory reference material.
Investigational — currently the subject of registered clinical trials; not yet authorised.
Licensed medicine — holds marketing authorisation in at least one jurisdiction. Prescription-only where indicated (POM).
Solvent / nutritional / cosmetic / blend — not a research peptide; classified by its actual category.
Metabolic research
Compound
Class / mechanism
Status
5-Amino-1MQ
Small-molecule NNMT inhibitor
Research use only
Adipotide / FTTP
Proapoptotic targeting peptide
Research use only — preclinical
AOD9604
Modified C-terminal hGH fragment
Research use only
Cagrilintide
Long-acting amylin analogue
Investigational
HGH Fragment 176-191
C-terminal fragment of human growth hormone
Research use only
L-Carnitine
Quaternary ammonium compound; fatty-acid transport cofactor
Nutritional compound
Lipo-C (with B12)
Methionine / choline / carnitine with cyanocobalamin
Compounded blend
Lipo-C (without B12)
Methionine / choline / carnitine preparation
Compounded blend
Mazdutide
GLP-1 / glucagon dual receptor agonist
Licensed in China
Retatrutide
GLP-1 / GIP / glucagon triple receptor agonist
Investigational — Phase 3
Semaglutide
GLP-1 receptor agonist
Licensed medicine (UK/US)
SLU-PP-332
Pan-ERR agonist (small molecule)
Research use only — preclinical
Survodutide
GLP-1 / glucagon dual receptor agonist
Investigational — Phase 3
Tirzepatide
GLP-1 / GIP dual receptor agonist
Licensed medicine (UK/US)
Growth hormone & IGF pathway
Compound
Class / mechanism
Status
CJC-1295 + Ipamorelin
Combined GHRH analogue and GHS-R agonist preparation
Research use only
CJC-1295 with DAC
GHRH analogue with albumin-binding Drug Affinity Complex
Research use only
CJC-1295 without DAC
Modified GRF(1-29)
Research use only
GHRP-2
GHS-R agonist hexapeptide
Research use only
GHRP-6
GHS-R agonist hexapeptide
Research use only
Hexarelin
Synthetic hexapeptide GH secretagogue
Research use only
HGH 191AA
Recombinant human growth hormone (somatropin, 191 aa)
Several compounds above hold marketing authorisation as medicines in the UK or elsewhere — among them somatropin, chorionic gonadotropin, oxytocin, botulinum toxin and the licensed GLP-1 receptor agonists. They appear here because they are part of the peptide research landscape and are frequently asked about. Their inclusion is descriptive. Licensed medicines are prescription-only and are not offered for human or animal use.
Strictly for laboratory research use only. Not for human or animal consumption. Nothing in this index constitutes medical, clinical or dosing guidance.
Educational content for laboratory research context only. Not medical, dosing or usage advice. All products are for laboratory research use only and are not for human or animal consumption.
See how our compounds are tested
Independent HPLC purity and Mass Spec identity data, published per compound.